Effectiveness of long-acting reversible contraception
- PMID: 22621627
- DOI: 10.1056/NEJMoa1110855
Effectiveness of long-acting reversible contraception
Abstract
Background: The rate of unintended pregnancy in the United States is much higher than in other developed nations. Approximately half of unintended pregnancies are due to contraceptive failure, largely owing to inconsistent or incorrect use.
Methods: We designed a large prospective cohort study to promote the use of long-acting reversible contraceptive methods as a means of reducing unintended pregnancies in our region. Participants were provided with reversible contraception of their choice at no cost. We compared the rate of failure of long-acting reversible contraception (intrauterine devices [IUDs] and implants) with other commonly prescribed contraceptive methods (oral contraceptive pills, transdermal patch, contraceptive vaginal ring, and depot medroxyprogesterone acetate [DMPA] injection) in the overall cohort and in groups stratified according to age (less than 21 years of age vs. 21 years or older).
Results: Among the 7486 participants included in this analysis, we identified 334 unintended pregnancies. The contraceptive failure rate among participants using pills, patch, or ring was 4.55 per 100 participant-years, as compared with 0.27 among participants using long-acting reversible contraception (hazard ratio after adjustment for age, educational level, and history with respect to unintended pregnancy, 21.8; 95% confidence interval, 13.7 to 34.9). Among participants who used pills, patch, or ring, those who were less than 21 years of age had a risk of unintended pregnancy that was almost twice as high as the risk among older participants. Rates of unintended pregnancy were similarly low among participants using DMPA injection and those using an IUD or implant, regardless of age.
Conclusions: The effectiveness of long-acting reversible contraception is superior to that of contraceptive pills, patch, or ring and is not altered in adolescents and young women. (Funded by the Susan Thompson Buffet Foundation.).
Comment in
-
Most women use less-effective contraceptive methods.J Midwifery Womens Health. 2012 Nov-Dec;57(6):636-637. doi: 10.1111/j.1542-2011.2012.00244_1.x. Epub 2012 Oct 18. J Midwifery Womens Health. 2012. PMID: 23217071 No abstract available.
Similar articles
-
Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.Am J Obstet Gynecol. 2017 Feb;216(2):101-109. doi: 10.1016/j.ajog.2016.08.033. Epub 2016 Sep 20. Am J Obstet Gynecol. 2017. PMID: 27662799 Free PMC article. Clinical Trial.
-
Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.Contraception. 2015 Dec;92(6):553-9. doi: 10.1016/j.contraception.2015.06.013. Epub 2015 Jun 17. Contraception. 2015. PMID: 26093190
-
Twenty-four-month continuation of reversible contraception.Obstet Gynecol. 2013 Nov;122(5):1083-1091. doi: 10.1097/AOG.0b013e3182a91f45. Obstet Gynecol. 2013. PMID: 24104781 Free PMC article.
-
Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.J Pediatr Adolesc Gynecol. 2016 Dec;29(6):659-667. doi: 10.1016/j.jpag.2016.06.007. Epub 2016 Jul 4. J Pediatr Adolesc Gynecol. 2016. PMID: 27386754 Review.
-
Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.Am J Obstet Gynecol. 2017 Apr;216(4):364.e1-364.e12. doi: 10.1016/j.ajog.2016.12.024. Epub 2016 Dec 28. Am J Obstet Gynecol. 2017. PMID: 28038902 Review.
Cited by
-
Safety profile of levonorgestrel intrauterine system: Analysis of spontaneous reports submitted to FAERS.Heliyon. 2024 Aug 28;10(17):e37112. doi: 10.1016/j.heliyon.2024.e37112. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39281579 Free PMC article.
-
An in-vivo study of the safety of copper-containing intrauterine devices in 3.0 Tesla magnetic resonance imaging.Abdom Radiol (NY). 2024 Dec;49(12):4592-4599. doi: 10.1007/s00261-024-04493-4. Epub 2024 Jul 18. Abdom Radiol (NY). 2024. PMID: 39023566 Free PMC article.
-
Offering extended use of the contraceptive implant via an implementation science framework: a qualitative study of clinicians' perceived barriers and facilitators.BMC Health Serv Res. 2024 Jun 3;24(1):697. doi: 10.1186/s12913-024-10991-4. BMC Health Serv Res. 2024. PMID: 38825705 Free PMC article.
-
Massachusetts' innovative policy approach to expanding contraceptive options in primary care.Health Aff Sch. 2023 Aug 24;1(3):qxad035. doi: 10.1093/haschl/qxad035. eCollection 2023 Sep. Health Aff Sch. 2023. PMID: 38756677 Free PMC article.
-
Long-acting intramuscular injections of ELQ-331, an antimalarial agent.Eur J Pharm Sci. 2024 Jul 1;198:106795. doi: 10.1016/j.ejps.2024.106795. Epub 2024 May 8. Eur J Pharm Sci. 2024. PMID: 38729224
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources